Clinical immersion programs are elective courses that offer continuing education for various life science teams as well as practicing clinicians. These programs are traditionally held in a clinical setting and meant to train attendees on a range of topics, including disease state education, competitive landscape, treatment patterns, and expert perspectives in the management of cancer […]

For the first time, breast cancer has overtaken lung cancer as the most commonly occurring malignancy globally, according to the World Health Organization (WHO). As stated in a UN briefing ahead of World Cancer Day 2021 by Dr Andre Ilbawi, a cancer specialist, breast cancer now accounts for nearly 12% of new cancer cases each […]

Chicago, IL  – April 26, 2021 — Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, announced today that it will make a majority investment in Aptitude Health Holdings, LLC (“Aptitude Health” or the “Company”) alongside the Company’s founder and management team. Headquartered in Atlanta, GA, Aptitude Health provides market insights and strategic solutions that […]

During the early months of the pandemic, convention halls were shuttered. Conferences were canceled as outreach activities rapidly shifted online. Many of us hoped these changes would prove temporary. But 1 year later, it is clear that the pandemic has permanently altered key opinion leader (KOL) outreach. Some companies are still scrambling to catch up. […]

The American Society of Clinical Oncology (ASCO) Clinical Cancer Advances 2021 report, published in February, highlights current trends in oncology and identifies cancer research priorities. A key focus of this year’s report is the issue of health equity in cancer research and solutions. While tremendous progress has been made in cancer prevention, early detection, and […]

If you have ever worked for a pharmaceutical company, you’ve likely heard the ubiquitous term “KOL” several dozen times. But do you know what—or rather who—a KOL actually is?

Current reports estimate that by 2030, approximately 12 million people diagnosed with cancer will be older than 70 years. Many older adults with cancer have multimorbidity and their health status can vary greatly. Therefore, treatment decisions based solely on chronologic age may put some older patients at risk for undertreatment or overtreatment. Comprehensive geriatric assessment […]

Digital features have become an integral part of many medical publications. While publishers have been adapting to this shift, clinical researchers and pharma in general have been slower to embrace the change. Many authors aren’t sure how to integrate digital features into their publications, or remain unconvinced that these features offer significant benefits. On the […]

Immune checkpoint inhibitors (ICIs) have had a rapid and broad expansion of their indications in recent months and are now the standard of care for many types of cancer. ICIs promote an antitumor immune response by inhibiting cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed cell death protein 1 /ligand 1 (PD-1/PD-L1), or both. However, this mechanism of […]

Digital features in medical publications are here to stay. These features offer unique benefits that make reading and sharing easier, and less time-consuming. If your organization has been slow to integrate digital features in medical publications, you may be missing out. Read on to learn more about the benefits of digitally enhanced medical publications. Digital Tools […]